CClinicalTrials.gg
Active, not recruitingNCT06728111REMAINUpdated Dec 11, 2024

Unraveling Perioperative Myocardial Injury

An observational study in Myocardial Injury and Myocardial Injury After Non-Cardiac Surgery, sponsored by Erasmus Medical Center. Active, not recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-11.

Sponsored by Erasmus Medical Center · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,114
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to gain insight into the etiology of myocardial injury after non cardiac surgery. Furthermore, suspected etiologies were explored and hierarchically classified into most likely cause how this determines prognosis and what factors are associated with improved outcome.

Read the detailed description

As above

02

Conditions studied

  • Myocardial Injury
  • Myocardial Injury After Non-Cardiac Surgery

Browse trials for

03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 859 are open to participants now.

This study's enrollment of 1,114 is above the median of 135 across 1,597 observational studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Erasmus Medical Center is the lead sponsor of 466 studies on the registry; 179 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The population to be studied consists of all non-cardiac surgical patients who underwent surgery at Erasmus MC in the period 2017-2023.

Inclusion criteria

  • Age > 18 year of age
  • Undergoing non-cardiac surgery in the Erasmus MC, with (high-sensitive) Troponin T > 50 ng/L measured in any of the first three days after surgery.

Exclusion criteria

Exclusion Criteria:

  • Re-operations within the study period.
  • Daycare surgery
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,114 participants (actual)
Patient registry
No

Interventions

  • OtherHigh sensitive Troponin T

    The baseline population will consist of all patients who underwent a form of non-cardiac surgery. Baseline variables, medication use, type of surgery and perioperative hemodynamic and laboratory variables will be extracted from the hospital information system. One year mortality is registered, as well as major vascular events. This is in line with previous publications from our group. The adjudication strategy used for patients with myocardial injury. For the adjudication process minimal two senior anesthesiologists will be invited. Two members with at least one senior anesthesiologist will receive a sample of patients to adjudicate. Together the entire panel will adjudicate all patients. The goal to investigate the differences between the raters.

06

What researchers measure

Primary outcomes

  1. Main etiologies elevated troponin T

    The primary endpoint is a description of the main etiologies found within patients with an elevated troponin T after non cardiac surgery.

    Time frame: from enrollment

Secondary outcomes

  1. Differences in adjudication

    Differences in the adjudication process between different doctors will be assessed according to intraclass coeficients and Fleisch Kappa

    Time frame: from enrollment

07

Study locations

1 site
  • Erasmus Medical Center
    Rotterdam, Netherlands
08

References and documents

Study documents

  • Study protocol · Sep 26, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06728111
Lead sponsor
Erasmus Medical Center
Responsible party
Felix van Lier (Anesthesiologist, Erasmus Medical Center) — Principal investigator
First posted
Dec 11, 2024
Start date
Jul 24, 2023
Primary completion
Mar 1, 2025 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Dec 11, 2024

Study contacts

Sanne Hoeks, PhD
study director · Epidemiologist
Felix van Lier, PhD
principal investigator · Anesthesiologist

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion